S&P ASX All Technology

US Dollar vs AUD

Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.

Get Started

EYPT EyePoint Pharmaceuticals Inc

9.11

0.00 (0.00%)

09 Jan 2025 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals (NASDAQ:EYPT)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more EyePoint Pharmaceuticals Charts.

EyePoint Pharmaceuticals Inc News

Form 4 - Statement of changes in beneficial ownership of securities
Thursday 9 January 2025 (14 hours ago) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Thursday 9 January 2025 (14 hours ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 8 January 2025 (23 hours ago) • Edgar (US Regulatory)

EyePoint Appoints Renowned Retina Specialist and Industry Pioneer Reginald J. Sanders, M.D., FASRS to Board of Directors
Wednesday 8 January 2025 (23 hours ago) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 January 2025 (2 days ago) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Wednesday 8 January 2025 (2 days ago) • Edgar (US Regulatory)

EyePoint to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Tuesday 17 December 2024 (3 weeks ago) • GlobeNewswire Inc.

EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Monday 16 December 2024 (3 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Wednesday 4 December 2024 (1 month ago) • Edgar (US Regulatory)

More EyePoint Pharmaceuticals Inc News Articles

S&P ASX 300 Metals and M...

Woodside Petroleum

Commonwealth Bank Of Aus...

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions